Login / Signup

Returning Incidental Research Findings from FDG PET/CT to Participants: A Survey of Investigators from a Clinical Trial of Rheumatoid Arthritis.

Jane S KangHoward F AndrewsJon T GilesKatherine P LiaoDaniel H SolomonJoan M Bathon
Published in: Arthritis care & research (2024)
While it is recommended that researchers report and manage incidental research findings, our data show differing views and uncertainties on what and how to return, and the extent of follow up needed to manage, incidental findings from whole body FDG PET/CT; this highlights the need for more specific and standardized guidance.
Keyphrases
  • clinical trial
  • rheumatoid arthritis
  • electronic health record
  • study protocol
  • big data
  • open label
  • phase ii
  • double blind
  • deep learning
  • artificial intelligence
  • systemic sclerosis